Apaf-1 is a transcriptional target for E2F and p53
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Loss of function of the retinoblastoma protein, pRB, leads to lack of differentiation, hyperproliferation and apoptosis. Inactivation of pRB results in deregulated E2F activity, which in turn induces entry to S-phase and apoptosis. Induction of apoptosis by either the loss of pRB or the deregulation of E2F activity occurs via both p53-dependent and p53-independent mechanisms. The mechanism by which E2F induces apoptosis is still unclear. Here we show that E2F1 directly regulates the expression of Apaf-1, the gene for apoptosis protease-activating factor 1. These results provide a direct link between the deregulation of the pRB pathway and apoptosis. Furthermore, because the pRB pathway is functionally inactivated in most cancers, the identification of Apaf-1 as a transcriptional target for E2F might explain the increased sensitivity of tumour cells to chemotherapy. We also show that, independently of the pRB pathway, Apaf-1 is a direct transcriptional target of p53, suggesting that p53 might sensitize cells to apoptosis by increasing Apaf-1 levels.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“abnormal proliferation that is induced by loss of RB is often accompanied by increased cell death, through p53-dependent and independent mechanisms49,57,87–91.”
From Cellular mechanisms of tumour suppression by the retinoblastoma gene (2008) · cites this paper as [90]
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Hengartner, M. O. (2000) · Nature · doi:10.1038/35037710 · Cited by 5,779
Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379 · cited 1×
“Consistent with this role, the pRB pathway is deregulated in most human cancers (reviewed in ref”
BackgroundThe regulation of E2F by pRB-family proteins.
Dyson, N. (1998) · Genes & Development · doi:10.1101/gad.12.15.2245 · Cited by 2,317 · cited 1×
“The best-characterized targets for the pRB family members are the E2F transcription factor”
BackgroundA Matter of Life and Cell Death
Evan, G., & Littlewood, T. (1998) · Science · doi:10.1126/science.281.5381.1317 · Cited by 1,523 · cited 1×
“Increased levels of Apaf-1 as a result of increased E2F activity could provide an explanation for the greater sensitivity of tumour cells to a variety of apoptosis-inducing agents, including chemotherapeutic drug”
BackgroundApaf1 Is Required for Mitochondrial Pathways of Apoptosis and Brain Development
Yoshida, H., Kong, Y.-Y., Yoshida, R., Elia, A. J., Hakem, A., Hakem, R., Penninger, J. M., & Mak, T. W. (1998) · Cell · doi:10.1016/s0092-8674(00)81733-x · Cited by 1,138 · cited 1×
“Apaf-1 is an essential stimulator of caspase activity and is required for stress- and oncogene-induced apoptosi”
BackgroundThe coordinate release of cytochrome c during apoptosis is rapid, complete and kinetically invariant
Goldstein, J. C., Waterhouse, N. J., Juin, P., Evan, G. I., & Green, D. R. (2000) · Nature Cell Biology · doi:10.1038/35004029 · Cited by 1,071
Inactivation of the apoptosis effector Apaf-1 in malignant melanoma
Soengas, M. S., Capodieci, P., Polsky, D., Mora, J., Esteller, M., Opitz-Araya, X., McCombie, R., Herman, J. G., Gerald, W. L., Lazebnik, Y. A., et al. (2001) · Nature · doi:10.1038/35051606 · Cited by 966 · cited 1×
“This suggestion was further substantiated by results—published while this manuscript was undergoing review—showing that Apaf-1 expression is lost in a number of malignant melanomas owing to a combination of allelic loss and transcriptional silencin”
Resultp73 is a human p53-related protein that can induce apoptosis
Jost, C. A., Marin, M. C., & Jr, W. G. K. (1997) · Nature · doi:10.1038/38298 · Cited by 948
p14ARF links the tumour suppressors RB and p53
Bates, S., Phillips, A. C., Clark, P. A., Stott, F., Peters, G., Ludwig, R. L., & Vousden, K. H. (1998) · Nature · doi:10.1038/25867 · Cited by 918
Cited by
Items 401–500 of 707
Hossain, S., Iwasa, H., Sarkar, A., Maruyama, J., Arimoto‐Matsuzaki, K., & Hata, Y. (2018) · Molecular and Cellular Biology · doi:10.1128/mcb.00046-18 · Cited by 22
“For instance, E2F1 regulates apoptosis-related genes, such as APAF1 and CASPs (49, 50).”
BackgroundMicromanagement of the mitochondrial apoptotic pathway by p53
Walia, V., Kakar, S., & Elble, R. (2010) · Frontiers in bioscience · doi:10.2741/3717 · Cited by 22
Li, Z., Kreutzer, M., Mikkat, S., Miše, N., Glocker, M. O., & Pützer, B. M. (2006) · PROTEOMICS · doi:10.1002/pmic.200600290 · Cited by 22
Punarnavine induces apoptosis in B16F-10 melanoma cells by inhibiting NF-kappaB signaling.
Manu, K. A., & Kuttan, G. (2009) · PubMed · Cited by 22
Hou, W., Yulin, H., Yang, W., Tian, T., Fang, P., Du, Y., Gao, L., Gao, Y., & Zhang, Q. (2021) · Drug Design Development and Therapy · doi:10.2147/dddt.s308713 · Cited by 21
The p53 Family in Brain Disease
Agostini, M., Melino, G., & Bernassola, F. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7302 · Cited by 21
“Indeed, a range of cellular insults, including excitotoxicity, oxidative, and genotoxic stress, lead to stabilization of p53, which, in turn, transcriptionally regulates the expression of proapoptotic genes such as Bax , Peg3/Pw1 (34), and Apaf-1 (101).”
Sun, C.-Y., Liu, Y., Feng, L., Jiang, W., Wu, P., Jiang, J., Kuang, S., Tang, L., & Zhou, X. (2021) · Aquaculture · doi:10.1016/j.aquaculture.2021.736360 · Cited by 21
pRb-E2F signaling in life of mesenchymal stem cells: Cell cycle, cell fate, and cell differentiation
Popov, B. V., & Ns, P. (2014) · Genes & Diseases · doi:10.1016/j.gendis.2014.09.007 · Cited by 21
“These genes were previously shown to be regulated by E2F1-3.(66,67) In contrast, loss of p107/p130 alters expression of genes regulating quiescent state in response to growth or differentiation signals.”
BackgroundHughes, T. A., & Brady, H. J. M. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.02.102 · Cited by 21
Mechanism of E2F1-induced apoptosis in primary vascular smooth muscle cells
Stanelle, J., Stiewe, T., Rödicker, F., KOHLER, K., Theseling, C. C., & Pützer, B. M. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(03)00392-4 · Cited by 21
Silencing of APAF‐1 in B‐CLL results in poor prognosis in the case of concomitant p53 mutation
Sturm, I., Bosanquet, A. G., Radetzki, S., Hummel, M., Dörken, B., & Daniel, P. T. (2005) · International Journal of Cancer · doi:10.1002/ijc.21535 · Cited by 21
“Recent evidence identified APAF-1, a key component of the apoptosome,(41,42) to be transcriptionally induced by p53.(5,6)”
BackgroundRole of E2F1 in Apoptosis: A case Study in Feedback Loops
Knezevic, D., & Brash, D. E. (2004) · Cell Cycle · doi:10.4161/cc.3.6.907 · Cited by 21
Coordination of miR-192 and miR-22 in p53-Mediated Cell Fate Decision
Sun, C., Zhang, X., & Wang, W. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194768 · Cited by 20
“Supplementary Materials: The following are available online at http://www.mdpi.com/1422-0067/20/19/4768/ s1, Figure S1: Heat map of [Bax] (A) and [Apaf-1] (B) as a function of Time and DD, Table S1: Variables and their initial values, Table S2: Parameter Values.”
BackgroundInfluentialSengupta, T., Abraham, G., Xu, Y., Clurman, B. E., & Minella, A. C. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05089-11 · Cited by 20
“To test the validity of these predicted sites, we cotransfected 293T cells with a luciferase reporter construct containing the HIF1A promoter region and either wild-type E2F-1 or an E2F-1 mutant that is defective for DNA binding (E2F-1–E132) (37).”
BackgroundInfluentialChen, B., Wen, P., Hu, G., Gao, Y., Qi, X., Zhu, K., Chen, S., Wu, L., Xu, A., & Zhao, G. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00408 · Cited by 20
E2F1 suppresses skin carcinogenesis via the ARF-p53 pathway
Russell, J., Weaks, R. L., Berton, T. R., & Johnson, D. G. (2005) · Oncogene · doi:10.1038/sj.onc.1209120 · Cited by 21
“E2F1-mediated apoptosis has been associated with the transcriptional upregulation of a number of target genes including multiple members of the caspase family and Apaf1 (Moroni et al., 2001; Nahle et al., 2002).”
BackgroundLieman, J. H., Worley, L. A., & Harbour, J. W. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m409371200 · Cited by 20
E2F1 inhibits MDM2 expression in a p53-dependent manner
Tian, X., Chen, Y., Hu, W., & Wu, M. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.09.003 · Cited by 19
Takahashi, A., Suzuki, H., Omori, K., Seki, M., Hashizume, T., Shimazu, T., Ishioka, N., & Ohnishi, T. (2010) · International Journal of Radiation Biology · doi:10.3109/09553001003789596 · Cited by 19
“…by p53 are apoptosis-related genes [e.g., AIF, apoptosis inducing-factor (Stambolsky et al. 2006); Apaf1, apoptosis protease activator protein-1 (Moroni et al. 2001); Bax, Bcl-2 associated Xprotein (Miyashita and Reed 1995); DR4, death receptor 4 (Guan et al. 2001); DR5, death receptor 5…”
BackgroundKalejta, R. F. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20177 · Cited by 19
“E2F-1 induces apoptosis through multiple pathways by transcriptionally activating pro-apoptotic genes such as p19ARF [Ginsberg, 2002], caspaces [Nahle et al., 2002], APAF-1 [Moroni et al., 2001], and the checkpoint kinase Chk2 [Rogoff et al., 2004].”
BackgroundMaking Connections: p53 and the Cathepsin Proteases as Co-Regulators of Cancer and Apoptosis
Soond, S. M., Savvateeva, L. V., Makarov, V. A., Gorokhovets, N. V., Townsend, P. A., & Zamyatnin, A. A. (2020) · Cancers · doi:10.3390/cancers12113476 · Cited by 18
“Here, p53-mediated death can be arrived at through the up-regulated expression of BAX [41], APAF-1 [35,36], NOXA [37], PUMA [38,39], BIM [42,43], Bcl-2 suppression [44], Bcl-xL [46–48], and Mcl-1 suppression [49,50].”
BackgroundEi24, a Novel E2F Target Gene, Affects p53-independent Cell Death upon Ultraviolet C Irradiation
Sung, Y. H., Jin, Y., Kang, Y., Devkota, S., Lee, J., Roh, J.-I., & Lee, H. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.477570 · Cited by 18
“Consistent with this finding, known E2F target genes including apoptosis protease-activating factor 1 (Apaf1) (23) and Stathmin (22)were also up-regulated inRb / MEFs (Fig.”
BackgroundThamkachy, R., Kumar, R., Rajasekharan, K. N., & Sengupta, S. (2016) · Molecular Cancer · doi:10.1186/s12943-016-0505-7 · Cited by 18
“p53 also plays a major role in the intrinsic pathway of apoptosis by the induction of Bax [11], Puma [12], Noxa [13] and APAF-1 [14–16] which facilitate the release of cytochrome c from the mitochondria.”
BackgroundAvitabile, M., Lasorsa, V. A., Cantalupo, S., Cardinale, A., Cimmino, F., Montella, A., Capasso, D., Haupt, R., Amoroso, L., Garaventa, A., et al. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15058 · Cited by 18
P53, Cell Cycle Arrest and Apoptosis
Wang, S., & El‐Deiry, W. S. (2005) · Springer eBooks · doi:10.1007/978-1-4020-2922-6_6 · Cited by 18
Mechanizmy oporności komórek nowotworowych na apoptozę
Bielak-Żmijewska, A. (2003) · Cited by 17
Yang, W., Yulin, H., Hou, W., Fang, X., Fang, P., Jiang, T., Ma, C., & Zhang, Q. (2019) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2019/8108503 · Cited by 17
“In the p53-independent apoptosis pathway, E2F1 directly activated some apoptotic genes, such as p73, the homologous gene of p53 [33], and Apoptotic protease activating factor 1 (Apaf-1) [34], thereby activating the proapoptotic effector enzymes caspase-3, caspase-6, and caspase-7 and inducing apoptosis [35].”
BackgroundHu, M., & Palić, D. (2020) · Toxicology Reports · doi:10.1016/j.toxrep.2020.05.007 · Cited by 17
“One example is the involvement of APAF-1 (apoptotic protease activating factor 1) in regulation of DNA damage-induced apoptosis by acting as a p53 downstream factor [55].”
BackgroundIdentification of a Novel Rb-regulated Gene Associated with the Cell Cycle
Sung, Y. H., Kim, H. J., & Lee, H. (2007) · Molecules and Cells · doi:10.1016/s1016-8478(23)07357-0 · Cited by 18
Creton, S. K., Zhu, H., & Gooderham, N. J. (2005) · Toxicological Sciences · doi:10.1093/toxsci/kfi075 · Cited by 17
“However, while E2F is important for the stimulation of proliferation, it also plays a role in apoptosis following DNA damage by inducing the expression of the pro-apoptotic factors Apaf-1, caspase 3, and p73 mRNA (Irwin et al., 2000; Matsumura et al., 2003;Moroni et al., 2000).”
BackgroundChe, Y., Best, G., Zhong, L., Alexander, K. L., Mactier, S., Raftery, M. J., Graves, L. M., Mulligan, S. P., & Christopherson, R. I. (2013) · Journal of Proteome Research · doi:10.1021/pr301055y · Cited by 16
Ashur‐Fabian, O., Adamsky, K., Trakhtenbrot, L., Cohen, Y., Raanani, P., Hardan, I., Nagler, A., Rechavi, G., & Amariglio, N. (2007) · Cell Cycle · doi:10.4161/cc.6.5.3900 · Cited by 16
Manickavinayaham, S., Singh, A. K., & Kumar, V. (2013) · Journal of Cell Science · doi:10.1242/jcs.126235 · Cited by 16
“E2F1 is also known to support apoptotic DNA damage response (DDR) in a p53-dependent or -independent manner (Bates et al., 1998; Moroni et al., 2001), so next we analysed selected E2F1 targets involved in apoptosis.”
BackgroundTakahashi, A., Suzuki, H., Omori, K., Seki, M., Hashizume, T., Shimazu, T., Ishioka, N., & Ohnishi, T. (2012) · Journal of Radiation Research · doi:10.1269/jrr.11140 · Cited by 16
Goodnight, A., Kremsky, I., Khampang, S., Jung, Y. H., Billingsley, J. M., Bosinger, S. E., Corces, V. G., & Chan, A. W. S. (2019) · Epigenetics & Chromatin · doi:10.1186/s13072-019-0313-6 · Cited by 18
Band, M., Ashur‐Fabian, O., & Avivi, A. (2010) · Cell Cycle · doi:10.4161/cc.9.16.12712 · Cited by 16
“Apaf1 is a p53 primary target containing p53 response elements (p53RE) within its promoter region.(27,28) We cloned the Spalax Apaf1 promoter and mdm2 intronic regions containing Figure 1.”
BackgroundLu, C., Chen, J., Zhou, G., Wu, S., Guan, Y.-F., & Yuan, C.-S. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn426 · Cited by 16
Zhang, J., Bahí, N., Zubiaga, A. M., Comella, J. X., Llovera, M., & Sanchís, D. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.11.046 · Cited by 15
Adenovirus E2F1 Overexpression Sensitizes LNCaP and PC3 Prostate Tumor Cells to Radiation In Vivo
Udayakumar, T. S., Stoyanova, R. S., Hachem, P., Ahmed, M. M., & Pollack, A. S. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.08.013 · Cited by 15
“(v) Transcriptional activation of Apaf-1, a protein that directly interacts with cytochrome C to initiate apoptotic proteolytic cascade is induced by E2F1 (28).”
Petrovic, V., Malin, D., & Cryns, V. L. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2465-6 · Cited by 14
“the intrinsic apoptotic pathway, and p53-independent apoptosis by E2F-dependent transcription of procaspases, which ‘‘primes’’ cells for apoptosis induction by lowering the threshold for caspase activation [3, 4].”
Bauzon, F., & Zhu, L. (2010) · Cell Cycle · doi:10.4161/cc.9.11.11726 · Cited by 14
“While E2F transcription factors can promote cell proliferation, they, in particular the E2F1 member, can also induce apoptosis by activating expression of apoptotic genes.(16,17) Since the same proteins stimulate cell proliferation and cell death, this safeguard mechanism seems to provide the “safest” defense against…”
BackgroundPleiotropic effect of somatic mutations in the E2F subunit DP-1 gene in human cancer
Munro, S., Oppermann, U. C. T., & Thangue, N. B. L. (2013) · Oncogene · doi:10.1038/onc.2013.316 · Cited by 14
Cell death in glioblastoma and the central nervous system
Malone, K., LaCasse, E. C., & Beug, S. T. (2024) · Cellular Oncology · doi:10.1007/s13402-024-01007-8 · Cited by 13
Mechanisms of UV-induced human lymphocyte apoptosis
Nakvasina, M. A., Holyavka, M. G., Artyukhov, V. G., Radchenko, M. S., & Лидохова, О. В. (2023) · Biophysical Reviews · doi:10.1007/s12551-023-01142-w · Cited by 13
Turowska, O., Nauman, A., Pietrzak, M., Popławski, P., Master, A., Nygård, M., Bondesson, M., Tański, Z., & Puzianowska‐Kuźnicka, M. (2007) · Thyroid · doi:10.1089/thy.2007.0075 · Cited by 13
Knockdown of E2f1 by RNA interference impairs proliferation of rat cells in vitro
Vasques, L. R., Pujiz, R. S., Strauss, B. E., & Krieger, J. E. (2009) · Genetics and Molecular Biology · doi:10.1590/s1415-47572009005000104 · Cited by 13
“E2F1, in response to DNA damage, can induce apoptosis by regulating related genes in a p53-dependent and p53-independent manner (Bates et al., 1998; Irwin et al., 2000; Lissy et al., 2000; Moroni et al., 2001).”
BackgroundFei, J., & de Villiers, E. (2008) · International Journal of Cancer · doi:10.1002/ijc.23506 · Cited by 13
p14ARF inhibits the growth of p53 deficient cells in a cell-specific manner
Li, Y., He, L., Bruce, A., Parihar, K., Ingram, A. J., Liu, L., & Tang, D. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.04.011 · Cited by 13
“The same results were also obtained using th (For interpretation of the references to colour in this figure legend, the reader is refe transfected 293 p14 cells with a luciferase reporter driven by either Apaf1 or p14 promoter, two E2F1 responsible promoters [46,47].”
ResultPustylnyak, V. O., Lisachev, P. D., & Shtark, M. B. (2015) · Neural Plasticity · doi:10.1155/2015/242158 · Cited by 12
Ghiasi, P., Hosseinkhani, S., Ansari, H., Aghdami, N., Balalaei, S., Pahlavan, S., & Baharvand, H. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26758 · Cited by 12
“It has been reported previously that APAF‐1 is a key transcriptional target for P53 (Bao & Shi, 2007; Moroni et al., 2001; Robles, Bemmels, Foraker, & Harris, 2001; Yun et al., 2016).”
BackgroundRetractedFranco-Juárez, E. X., González-Villasana, V., Camacho-Moll, M. E., Rendón-Garlant, L., Ramírez-Flores, P. N., Silva-Ramírez, B., Peñuelas-Urquides, K., Cabello-Ruiz, E. D., Castorena‐Torres, F., & de León, M. B. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031760 · Cited by 12
“The E2F1/p53 transcription-dependent mechanism relies on the expression of multiple genes that have been reviewed elsewhere [66], including those known to promote apoptosis such as PUMA , NOXA and BIM [67,68].”
BackgroundZhang, Y., & Herman, B. A. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21666 · Cited by 12
“One important transcription factor, p53, has been demonstrated to either up-regulate proapoptotic or down-regulate anti-apoptotic genes [Moroni et al., 2001].”
BackgroundIdentification of the novel role of pRB in eye cancer
Lai, H. C., Ma, F., & Lai, S. (2002) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10283 · Cited by 12
“It has been suggested that the ability of E2F1, E2F2, and E2F3 to induce apoptosis correlates with their ability to activate expression of APAF1 [Moroni et al., 2001].”
BackgroundInterplay Between Cyclin-Dependent Kinases and E2F-Dependent Transcription
Ji, J., & Dyson, N. J. (2010) · Springer eBooks · doi:10.1007/978-1-4419-1770-6_2 · Cited by 12
Fearnhead, H. O. (2004) · Cancer Biology & Therapy · doi:10.4161/cbt.3.1.538 · Cited by 12
Lee, W. T., Lee, S. H., Carriedo, S. G., Giffard, R. G., Yoon, Y. J., Kim, J. H., Park, K. A., & Lee, J. E. (2002) · Molecules and Cells · doi:10.1016/s1016-8478(23)15105-3 · Cited by 12
Mallucci, L., Wells, V., Danikas, A., & Davies, D. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00512-4 · Cited by 14
E2F and p53 make a nice couple: converging pathways in apoptosis
Dynlacht, B. D. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401612 · Cited by 12
The Translational Regulators GCN-1 and ABCF-3 Act Together to Promote Apoptosis in C. elegans
Hirose, T., & Horvitz, H. R. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004512 · Cited by 11
“For example, in mammals the genes that encode the pro-apoptotic BCL-2 family member BAX, the BH3-only proteins NOXA, PUMA and BID, the apoptotic protease-activating factor1 APAF-1 and the death receptor 5 DR5 protein are transcriptionally upregulated by the tumor suppressor p53 transcription factor in response to DNA…”
BackgroundLoss of VHL-mediated pRb regulation promotes clear cell renal cell carcinoma
Akuma, M., Kim, M., Zhu, C., Wiljer, E., Gaudreau-Lapierre, A., Patterson, L. D., Egevad, L., Tanguay, S., Trinkle‐Mulcahy, L., Stanford, W. L., et al. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07623-y · Cited by 11
Islam, M. S., Takano, R., Yokochi, T., Akter, J., Nakamura, Y., Nakagawara, A., & Tatsumi, Y. (2019) · BMC Cancer · doi:10.1186/s12885-019-5772-4 · Cited by 11
MARÍN, M. J., García, I., Peña, M., Bolívar, A., Zubiaga, A. M., & López‐Hoyos, M. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1361.057 · Cited by 11
MicroRNA-770-5p contributes to podocyte injury via targeting E2F3 in diabetic nephropathy
Guo, J., Han, J., Liu, J., & Wang, S. (2020) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20209360 · Cited by 11
“A previous study indicated that E2F3 regulates the expression of APAF1, which is necessary for E2F3induced apoptosis (29).”
BackgroundIncreased Levels and Activity of E2F1 Transcription Factor in Myelodysplastic Bone Marrow
Saberwal, G. S., Lucas, S., Janssen, İ., Deobhakta, A. A., Hu, W.-Y., Galili, N., Raza, A., & Mundle, S. D. (2004) · International Journal of Hematology · doi:10.1532/ijh97.na0303 · Cited by 10
Lim, Y., Hwang, W., Kim, J. Y., Lee, C. H., Kim, Y., Lee, D., & Kwon, O. (2019) · Scientific Reports · doi:10.1038/s41598-019-46289-3 · Cited by 10
Artyukhov, V. G., Ms, T., Nakvasina, M. A., & Solov’eva, E. V. (2011) · Cell and Tissue Biology · doi:10.1134/s1990519x11020039 · Cited by 10
Unbound E2F modulates TGF-β1-induced apoptosis in HuH-7 cells
Fan, G., Ma, X., Kren, B. T., & Steer, C. J. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.15.3181 · Cited by 10
Identification of E1AF as a Target Gene of E2F1-induced Apoptosis in Response to DNA Damage
Wei, Y., Liu, D., Ge, Y., Zhou, F., Xu, J., Chen, H., Gu, J., & Jiang, J. H. (2008) · The Journal of Biochemistry · doi:10.1093/jb/mvn098 · Cited by 10
Yang, Y., Sun, F., Zhang, C., Wang, H., Wu, G., & Wu, Z. (2013) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/2049-1891-4-28 · Cited by 9
“The E2F1 transcription factor has been well known for its ability to regulate cell cycle progression by controlling the expression of genes essential for the entry into the S phase of the cell cycle, such as CCNE1 (Cyclin E1) and CCNA2 (Cyclin A2) [24-26].”
BackgroundWong, C., Wu, Z., & Yu, Q. (2013) · Oncogene · doi:10.1038/onc.2013.72 · Cited by 9
Transcriptional Regulation of Apoptosis
Dudgeon, C., Qiu, W., Sun, Q., Zhang, L., & Yu, J. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-381-7_10 · Cited by 9
p53 Tumor Suppressor: Functional Regulation and Role in Gene Therapy
Farooq, Z., Wani, S., Ragunathrao, V. A. B., Kochhar, R. K., & Anwar, M. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.105029 · Cited by 8
A close link between Fas, p53 and Apaf-1 in chronic myeloid leukemia
Alenzi, F. Q., Wyse, R. K. H., Tamimi, W. G., Bamaga, M. S., & Lotfy, M. (2007) · Saudi Medical Journal · doi:10.15537/1658-3175.3989 · Cited by 8
Arendt, T. (2008) · Springer eBooks · doi:10.1007/978-0-387-32671-9_8 · Cited by 8
A genetic reporter system to gauge cell proliferation rate
Peacock, R. W. S., & Wang, C. L. (2011) · Biotechnology and Bioengineering · doi:10.1002/bit.23163 · Cited by 7
“Transfections were performed with varying amounts of expression vectors for DP-1 (200 ng plasmid DNA/well) and either E2F-1 or an E2F1 DNA binding mutant (pCMV-DP1, pCMV-E2F1, and pCMV-E2F1 E132, respectively – provided by K. Helin, University of Copenhagen, Denmark (Helin et al., 1993)).”
BackgroundInfluentialGomez, G. G., Hickey, M. J., Tritz, R., & Kruse, C. A. (2008) · PubMed · Cited by 7
Pathophysiology of Cancer Cell Death
Galluzzi, L., Linkermann, A., Kepp, O., & Kroemer, G. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-47674-4.00005-0 · Cited by 8
Modeling Cell Cycle Control and Cancer with pRB Tumor Suppressor
Yamasaki, L. (2006) · Springer eBooks · doi:10.1007/b136682 · Cited by 7
Ahmadi, Y., Mohammed, T., Abolhasani, S., Hamad, S. A., & Faiq, T. (2025) · Cell Cycle · doi:10.1080/15384101.2025.2599081 · Cited by 6
Prognostic value of IKBIP in papillary renal cell carcinoma
Zhang, H., Tang, R., Wen, X., Cai, J., Huang, J., Luo, L., & Yang, Z. (2023) · BMC Urology · doi:10.1186/s12894-023-01290-x · Cited by 6
“According to previous reports, APAF1 plays an important role in apoptosis and p53 has been shown to induce the expression of APAF1 and IKBIP at the transcriptional level [6].”
BackgroundResultStephens, L. C., Milas, L., Ang, K. K., Mason, K. A., & Meyn, R. E. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-968-0_25 · Cited by 6
Multifaceted targeting in cancer: the recent cell death players meet the usual oncogene suspects
Drosopoulos, K. G., & Pintzas, A. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.5.641 · Cited by 6
“The APAF1 octamers can bind procaspase-9 molecules, via the caspase-recruting domains (CARDs), which are activated by autocatalytic cleavage.”
BackgroundInfluentialDependence of p53-deficient cells on the DHX9 DExH-box helicase
Lee, T., & Pelletier, J. (2017) · Oncotarget · doi:10.18632/oncotarget.15889 · Cited by 6
Roads to Stat3 Paved with Cadherins
Adan, H., Daniel, J. M., & Raptis, L. H. (2022) · Cells · doi:10.3390/cells11162537 · Cited by 6
“Interestingly, at the same time, E2F activates apoptosis genes [91,92], but apoptosis is prevented due to the activation of survival factors such as PI3k and Stat3 by tyrosine kinase receptors induced by E2F itself, or directly by Src or other kinases, so that transformation does occur (Figure 1).”
BackgroundPathophysiology of Cancer Cell Death
Galluzzi, L., Kepp, O., & Kroemer, G. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-2865-7.00005-9 · Cited by 6
Adan, H., Guy, S., Arulanandam, R., Geletu, M., Daniel, J. M., & Raptis, L. H. (2022) · Cancer Gene Therapy · doi:10.1038/s41417-022-00462-5 · Cited by 6
“Interestingly, at the same time, E2F activates apoptosis through both p53-dependent and independent pathways [[51, 52]; reviewed in [53, 54]].”
BackgroundGray‐Schopfer, V. C., & Bennett, D. C. (2006) · Wiley eBooks · doi:10.1002/9780470987100.ch24 · Cited by 6
Dissertation zur Erlangung des akademischen Grades Doctor rerum naturalium (Dr.rer.nat.)
Schreyer, J. (2005) · Cited by 6
Fibronectin Modulates the Expression of miRNAs in Prostate Cancer Cell Lines
Martinucci, B., Cucielo, M. S., Minatel, B. C., Cury, S. S., Caxali, G. H., Aal, M. C. E., Felisbino, S. L., Pinhal, D., Carvalho, R. F., & Delella, F. K. (2022) · Frontiers in Veterinary Science · doi:10.3389/fvets.2022.879997 · Cited by 5
“Another molecule that showed outstanding enrichment in both PC-3 and LNCaP lineages and that was related to TP53 in the PPI was the anti-apoptotic factor MCL-1, a member of the BCL-2 family, and a predicted target of miR-29b, tumor suppressor, and interestingly is also target of miR-125b.”
BackgroundInfluentialTakeuchi, H., Koga, M., Doi, K., & Sakurai, H. (2023) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2023.194960 · Cited by 5
Wang, D., Yang, H., Zhou, Z. Y., Zhao, M., Chen, R., & Reed, S. H. (2018) · Toxicology Letters · doi:10.1016/j.toxlet.2018.02.022 · Cited by 5
E2F Transcription Factors in Cancer, More than the Cell Cycle
Broeker, C. D., & Andrechek, E. R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00102-x · Cited by 5
Rajasekaran, R., & Sethumadhavan, R. (2010) · Science China Life Sciences · doi:10.1007/s11427-010-0039-y · Cited by 5
VanDeusen, H. R., & Kalejta, R. F. (2015) · Journal of Virology · doi:10.1128/jvi.01718-15 · Cited by 5
Gene expression profiling of p53-sensitive and -resistant tumor cells using DNA microarray
Maxwell, S. A., & Davis, G. E. (2004) · APOPTOSIS · doi:10.1023/b:appt.0000018799.20120.38 · Cited by 5
Selective targeting of apoptotic pathways in follicular lymphoma cells
Włodkowic, D. (2007) · UEF eRepo (University of Eastern Finland) · Cited by 5
Splicing DNA Damage Adaptations for the Management of Cancer Cells
Singh, A. K., Yadav, D., & Malviya, R. (2023) · Current Gene Therapy · doi:10.2174/0115665232258528231018113410 · Cited by 4
p53 in Human Cancer — Somatic and Inherited Mutations and Mutation-independent Mechanisms
Moll, U. M., & Concin, N. (2007) · Springer eBooks · doi:10.1007/0-387-30127-5_6 · Cited by 4
Molecular and Cellular Basis of Chemoresistance in Ovarian Cancer
Asare-Werehene, M., Shieh, D., Song, Y. S., & Tsang, B. K. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813209-8.00035-2 · Cited by 4
Lee, J. E. (2011) · Molecular Medicine Reports · doi:10.3892/mmr.2011.561 · Cited by 4
“…p53 function in various studies as p53 is frequently mutated or inactivated in human gliomas. p53 stimulates transcriptional activation to regulate cell-cycle control, DNA repair and synthesis, and apoptosis (11,12), and also mediates the apoptotic pathway by inducing caspase-3 activation (13).”
Metadata
- Authors
- Moroni, M. C., Hickman, E. S., Denchi, E. L., Caprara, G., Colli, E., Cecconi, F., Müller, H., & Helin, K.
- Affiliations
- European Institute of Oncology (IT)
- University of Rome Tor Vergata (IT)
- Nerviano Medical Sciences (IT)
- Corresponding author
- Helin, Kristian
- ORCID
- Venue
- Nature Cell Biology
- Published
- 2001-05-10
- Volume
- 3
- Issue
- 6
- Pages
- 552-558
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- OpenAlex
- W1497251274
- Cited by
- 593
- References
- 38
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 3 · 2023: 9 · 2022: 5 · 2021: 7 · 2020: 10 · 2019: 14 · 2018: 11 · 2017: 9 · 2016: 9 · 2015: 15 · 2014: 9 · 2013: 22 · 2012: 22
- FWCI
- 27.94
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Cineca Institutional Research Information System (Tor Vergata University) (submittedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Funders
- Associazione Italiana per la Ricerca sul Cancro
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Keywords
- Apaf-1, E2F1, p53, retinoblastoma protein, transcriptional regulation, apoptosis, chemosensitivity, cancer cells, S phase entry
- MeSH terms
- Animals, DNA-Binding Proteins, Embryo, Mammalian, Humans, Promoter Regions, Genetic, Proteins, Transcription Factors, Transcription, Genetic, Transcriptional Activation, Tumor Suppressor Protein p53, Retinoblastoma Protein, Cell Cycle Proteins, E2F Transcription Factors, E2F1 Transcription Factor, Mice, Apoptotic Protease-Activating Factor 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.